Gabriel Carvalho dos Anjos Silva

Universidade de São Paulo

Papers

1

Total Citations

30

H-Index

1

About

Dr. Gabriel Carvalho dos Anjos Silva is a pioneering urologic surgeon whose work centers on advancing minimally invasive surgical techniques for renal cancer treatment. His landmark prospective, randomized controlled trial comparing open versus laparoscopic partial nephrectomy—cited 30 times since 2022—provides critical evidence supporting the safety and efficacy of laparoscopic approaches for renal tumors under 7 cm. This study addresses a significant gap in the literature, offering robust data that helps guide clinical decision-making and promotes wider adoption of less invasive procedures. Dr. Silva’s research directly impacts patient outcomes by reducing recovery times and surgical morbidity while maintaining oncologic efficacy. His commitment to rigorous clinical trials underscores his role as a leader in evidence-based urologic oncology, shaping modern surgical standards for nephron-sparing surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
30
Total Citations
30
Avg Citations/Paper
🏆 Most Cited Paper
A Prospective, Randomized Trial Comparing the Outcomes of Open vs Laparoscopic Partial Nephrectomy
30 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Universidade de São Paulo

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago